Category: Industry Updates

Small Nucleic Acid Drugs: Second Evolution
New Medicine 3.0
Three years interrupted by the pandemic
The next gold mine to be mined

Driven by environmental protection and food safety, the global bio-pesticide market is facing unprecedented development opportunities.

Recently, Science Media GEN spoke with Professor Robert Langer of the David H.Koch Institute at MIT about the present and future of mRNA vaccines as Moderna’s co-founder.

Recently, The clinical results of Molnupiravir (MK-4482, EIDD-2801), a novel coronavirus small molecule developed by Merk, are relatively exciting. Here is a focus for a

Last year, Moderna quickly developed a candidate vaccine based on mRNA technology after the releasing of the Novel Coronavirus genome sequence by Chinese scientists. It made mRNA technology an overnight success.

Covid-19 related drugs: Remdesiver, Favipiravir, Hydroxychloroquine, Chloroquine phosphate, and Azithromycin